Selenium supplementation in X-linked muscular dystrophy. Effects on erythrocyte and serum selenium and on erythrocyte glutathione peroxidase activity - PubMed (original) (raw)
Selenium supplementation in X-linked muscular dystrophy. Effects on erythrocyte and serum selenium and on erythrocyte glutathione peroxidase activity
M Gebre-Medhin et al. Acta Paediatr Scand. 1985 Nov.
Abstract
The selenium concentrations in serum and erythrocytes and the erythrocyte glutathione peroxidase activity were determined in 15 boys with the Duchenne type and in 5 boys with the Becker type of X-linked muscular dystrophy before and during long-term selenium and alpha-tocopherol supplementation and compared with values in unsupplemented controls. The purpose of the treatment was to improve the muscular strength. Twelve of the 20 patients had pretreatment levels of selenium in serum that were within the 95% confidence limit of the unsupplemented control children. The values in 2 patients, both with the Duchenne type of muscular dystrophy, fell below this level. Selenium supplementation in a daily dose of 6 micrograms/kg/day for 6 months caused a substantial rise in both serum and erythrocyte selenium, suggesting suboptimal pretreatment body contents of selenium. The greatest increases in both serum and erythrocyte selenium were observed in subjects with initially low selenium levels. Only in 4 of the 20 patients did the selenium supplementation result in a significant rise in erythrocyte glutathione peroxidase activity. As no sure improvement was noted in muscular strength during this treatment period, the Se dose was increased to 20 micrograms/kg/day. This resulted in a further rise in both serum and erythrocyte selenium, but not in erythrocyte glutathione peroxidase activity.
Similar articles
- Selenium metabolism and supplementation in patients with muscular dystrophy.
Jackson MJ, Coakley J, Stokes M, Edwards RH, Oster O. Jackson MJ, et al. Neurology. 1989 May;39(5):655-9. doi: 10.1212/wnl.39.5.655. Neurology. 1989. PMID: 2540451 Clinical Trial. - Increased plasma and erythrocyte selenium concentrations but decreased erythrocyte glutathione peroxidase activity after selenium supplementation in children with Down syndrome.
Annerén G, Gebre-Medhin M, Gustavson KH. Annerén G, et al. Acta Paediatr Scand. 1989 Nov;78(6):879-84. doi: 10.1111/j.1651-2227.1989.tb11167.x. Acta Paediatr Scand. 1989. PMID: 2532445 - Blood levels of superoxide dismutase and glutathione peroxidase in Duchenne muscular dystrophy.
Burri BJ, Chan SG, Berry AJ, Yarnell SK. Burri BJ, et al. Clin Chim Acta. 1980 Aug 4;105(2):249-55. doi: 10.1016/0009-8981(80)90467-2. Clin Chim Acta. 1980. PMID: 7398093 - [Selenium concentration in blood and Duchenne-type progressive muscular dystrophy].
Yamaguchi T. Yamaguchi T. Nihon Rinsho. 1996 Jan;54(1):134-40. Nihon Rinsho. 1996. PMID: 8587180 Japanese. - Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand.
Thomson CD, Robinson MF. Thomson CD, et al. Am J Clin Nutr. 1980 Feb;33(2):303-23. doi: 10.1093/ajcn/33.2.303. Am J Clin Nutr. 1980. PMID: 6766657 Review.
Cited by
- Understanding the importance of selenium and selenoproteins in muscle function.
Rederstorff M, Krol A, Lescure A. Rederstorff M, et al. Cell Mol Life Sci. 2006 Jan;63(1):52-9. doi: 10.1007/s00018-005-5313-y. Cell Mol Life Sci. 2006. PMID: 16314926 Free PMC article. Review. - The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
Coakley JH, Moorcraft J, Hipkin LJ, Smith CS, Griffiths RD, Edwards RH. Coakley JH, et al. J Neurol Neurosurg Psychiatry. 1988 Dec;51(12):1551-7. doi: 10.1136/jnnp.51.12.1551. J Neurol Neurosurg Psychiatry. 1988. PMID: 3221222 Free PMC article. - Cellular Stress in the Pathogenesis of Muscular Disorders-From Cause to Consequence.
Mensch A, Zierz S. Mensch A, et al. Int J Mol Sci. 2020 Aug 13;21(16):5830. doi: 10.3390/ijms21165830. Int J Mol Sci. 2020. PMID: 32823799 Free PMC article. Review. - Determination of selenium in blood components by X-ray emission spectrometry. Procedures, concentration levels, and health implications.
Robberecht H, Deelstra H, Van Grieken R. Robberecht H, et al. Biol Trace Elem Res. 1990 Jun;25(3):149-85. doi: 10.1007/BF02990412. Biol Trace Elem Res. 1990. PMID: 1698415 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials